CareDx, Inc. CDNA

CDNA Company Overview

CareDx, Inc. is a precision medicine company focused on the transplantation ecosystem, providing diagnostic testing, digital healthcare solutions, and laboratory services designed to improve outcomes for transplant patients. The company primarily operates in the organ transplant industry, with a concentration in kidney, heart, lung, and liver transplantation. Its core revenue drivers include molecular diagnostic testing services, transplant patient surveillance products, and digital and patient management solutions used by transplant centers and healthcare providers.

The company is best known for its non-invasive transplant diagnostics, particularly AlloSure and AlloMap testing platforms, which are used to monitor organ transplant rejection and graft health. CareDx also offers software and digital platforms that support transplant workflow management and patient engagement. Founded in 1998 and headquartered in Brisbane, California, the company evolved from a molecular diagnostics business into a vertically integrated transplant-focused healthcare company through internal development and acquisitions. Public filings and investor materials indicate that CareDx has positioned itself as one of the few companies offering an end-to-end transplant management platform spanning diagnostics, digital tools, and clinical services.